logo
Questions? +1 (202) 335-3939 Login
Set Up FREE Account Submit Release
Trusted News Since 1995
A service for pharmaceutical industry professionals · Wednesday, May 7, 2025 · 810,495,538 Articles · 3+ Million Readers
Home  •••  Newswires by Industry  •  Countries  •  U.S. States  •  World Media Directory
Pharmaceutical Industry News  •••  Topics  •  Countries  •  U.S. States

Huntington's Drugs News Monitoring

  • Published on May 5, 2025

    Why Did PTC Therapeutics Stock Fall On Monday Despite Mid-Stage Study For Huntington's Hits Primary Goal?

    PTC Therapeutics, Inc. PTCT on Monday announced results from the Phase 2 PIVOT-HD study of PTC518 (votoplam) in Stage 2 and Stage 3 Huntington’s disease (HD) patients. Huntington’s disease is a progressive neurodegenerative disorder caused by mutation of …

    Source: Benzinga - Neutral
  • Published on May 29, 2024

    French family battles Huntington's through sporting challenges

    Do you receive The Connexion's free weekday newsletter? Sign up here Climbing Kilimanjaro and cycling across Europe are just two of the gruelling sporting activities undertaken by a family directly affected by Huntington’s disease to shine a light on …

    Source: The Connexion - Neutral
  • Published on May 6, 2025

    PTC Therapeutics (PTCT) Q1 2025 Earnings Call

    Image source: The Motley Fool. DATE Tuesday, May 6, 2025 at 4:30 p.m. ET CALL PARTICIPANTS Chief Executive Officer — Matthew Klein Chief Operating Officer — Eric Pauwels Chief Financial Officer — Pierre Gravier SUMMARY PTC Therapeutics, Inc. (PTCT -10.85%) …

    Source: myMotherLode - Pending
  • Published on May 6, 2025

    PTC Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results

    – Strong revenue performance of $190 million –  – Positive CHMP opinion for Sephience™ (sepiapterin) received in April 2025, NDA review remains on track for July 29, 2025 PDUFA date –  – Global Sephience launch activities progressing well – – Strong cash …

    Source: WFMZ - Pennsylvania - Neutral
  • Published on May 6, 2025

    Neurocrine Biosciences to Present at Upcoming Investor Conferences in May

    SAN DIEGO, May 6, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will participate at two upcoming investor conferences in May. Chief Executive Officer Kyle Gano and Vice-President of Investor Relations Todd Tushla will present at …

    Source: WFMZ - Pennsylvania - Neutral
  • Published on May 6, 2025

    PTC's Huntington study was positive. Why did its stock fall?

    In a potentially pivotal trial, PTC Therapeutics' experimental therapy for Huntington's disease (HD) met its primary endpoint, but questions about the data have raised doubts about the company's ability to seek accelerated approval. The phase 2 …

    Source: pharmaphorum - Neutral
  • Published on May 5, 2025

    uniQure to Announce First Quarter 2025 Financial Results

    LEXINGTON, Mass. and AMSTERDAM, the Netherlands, May 05, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs will report first quarter 2025 financial …

    Distribution channels:
  • Published on May 5, 2025

    Huntington Drug PTC518 Meets Primary End Point in Phase 2 Study

    According to a new announcement from PTC Therapeutics, investigational PTC518 met its primary end point in the phase 2 PIVOT-HD study (NCT05358717), with results showing a statistically significant change in blood Huntingtin (HTT) protein levels over a 12- …

    Source: NeurologyLive - Neutral
  • Published on May 2, 2025

    What to Expect from Neurocrine Biosciences's Earnings

    Neurocrine Biosciences NBIX is set to give its latest quarterly earnings report on Monday, 2025-05-05. Here's what investors need to know before the announcement. Analysts estimate that Neurocrine Biosciences will report an earnings per share (EPS) of …

    Source: Benzinga - Neutral
  • «
  • 1
  • »

05 days 04:48:23

Featured Releases

Got News to Share? · Submit · See All
Got news to share? Submit it now.
Load more pharmaceuticals news or search news using your own keywords. There are 810,495,538 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country >
Pharmaceutical Industry News by U.S. State >
Pharmaceutical Industry News Topics >
Online News Publications >
World News Report >

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter >
Create RSS Feed >
NewsPlugin for WordPress >

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire >
Events >

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 04/18/2025

World Media Directory >

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All
Got news to share? Submit it now.

Healthcare & Pharmaceuticals Events

See All

No event was found.

Become a Member - Join Today!
Join thousands of professionals. Stay current. Stay competitive.
  • Track news from thousands of sources
  • Submit news sources for inclusion in our news tracking algorithm
  • Build your own customized email newsletters
  • Use of our RSS Feeds
  • Includes a complimentary EIN Presswire account plus 1-free release
  • Uncluttered & advertising free news pages

Pharmaceutical Industry Today by EIN Newsdesk & EIN Presswire (a press release distribution service)

Follow us on Facebook and connect with us on LinkedIn

Newsmatics Inc., 1025 Connecticut Avenue NW, Suite 1000, Washington, DC 20036 · Contact · About

© 1995-2025 Newsmatics Inc., a publisher of EIN News · All Rights Reserved · Privacy Policy · User Agreement